TrialSignal
Clinical trial intelligence report
Development and Application of Appropriate Technology for Obesity Prevention and Control -- Study on Personalized Aerobic and Appropriate Exercise Technology
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 24, 2026
Report code
NCT02074332-Jun 24, 2026
NCT ID
NCT02074332
Status
COMPLETED
Phase
Not applicable; this is an interventional study without a defined clinical phase.
Sponsor
Hai-Jun Wang
Executive brief
Investment-Ready Snapshot
The study, sponsored by Hai-Jun Wang at Peking University, investigates a school-based physical activity program aimed at preventing and controlling obesity among children aged 7 to 15. Given the rising prevalence of pediatric obesity, this intervention addresses a significant public health concern. The results could inform future educational policies and health programs, potentially leading to partnerships with educational institutions and health organizations. The competitive landscape includes various obesity intervention programs, but the focus on personalized aerobic and appropriate exercise technology may differentiate this approach. Diligence should consider the scalability of the intervention and the potential for integration into existing school curricula.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT02074332
Indication
Pediatric Obesity
Modality
behavioral intervention
Target
Not applicable; the study focuses on behavioral interventions rather than a specific molecular or mechanistic target.
Intervention
Physical activity guidance, Health education
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.